Using abundance measurements with ubiquitination data, mass spectrometry provides a systems-level view of how disease perturbs protein homeostasis. Mass spectrometry–based proteomics is especially important for studying disease because it allows direct measurement of protein abundance changes while also capturing regulatory mechanisms that cannot be inferred from gene or mRNA data alone. In many diseases, proteins are up- or down-regulated not because of altered transcription, but because of changes in stability and turnover. Since proteins are the functional molecules that execute cellular processes, observing their actual levels provides a more accurate picture of disease biology than genomics or transcriptomics alone. Ubiquitination plays a central role in controlling protein degradation, signaling, and cellular quality control, and its dysregulation is a hallmark of many diseases, including cancer, neurodegenerative disorders, and inflammatory conditions. Mass spectrometry proteomics enables the identification and quantification of ubiquitinated proteins and specific ubiquitination sites, allowing researchers to see which proteins are being selectively targeted for degradation or altered signaling. This is critical for understanding disease mechanisms where abnormal protein accumulation or excessive protein loss drives pathology, such as the buildup of misfolded proteins in neurodegeneration or the enhanced degradation of tumor suppressors in cancer. By integrating protein abundance measurements with ubiquitination data, mass spectrometry provides a systems-level view of how disease perturbs protein homeostasis. Researchers can distinguish whether changes in protein levels arise from altered synthesis or from ubiquitin-mediated degradation, and they can map entire pathways affected by disrupted ubiquitin signaling. This makes mass spec proteomics a powerful tool for identifying disease biomarkers, uncovering therapeutic targets within the ubiquitin–proteasome system, and evaluating how drugs modulate protein stability and turnover in disease contexts. LifeSensors’s TUBEs offers the most natural way of studying ubiquitination without modifying the target, or the ubiquitin chain, especially important for avoiding artifacts in such a valuable research tool.
Compiled from http://www.lifesensors.com
